NEW ENGLAND BIOLABS, INC.
Doing business as NEW ENGLAND BIOLABS INC
- IPSWICH, MA 01938-2723
- neb.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $378.6K
- Awards on record
- 13
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
NEW ENGLAND BIOLABS, INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About NEW ENGLAND BIOLABS, INC.
- Headquarters
- IPSWICH, MA 01938-2723
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIEDKJNT8DADG8
- CAGE00UJ1
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $378.6K
- Awards on record
- 13
- Top funding agencies
- National Institutes of Health · Smithsonian Institution
Awards
75N98026P01401
Recompete 6–12 mo: Potential end Sep 1, 2027 (9 months away)NEW ENGLAND BIOLABS:1105931 [26-002792]
Department of Health and Human Services · National Institutes of Health
- Obligated
- $59.5K
- Period of performance
- Sep 2, 2026 – Sep 1, 2027
33315225P00527670
Completed: Period of performance ended Sep 30, 2025SCIENTIFIC SUPPLIES
Smithsonian Institution
- Obligated
- $13.3K
- Period of performance
- Aug 5, 2025 – Sep 30, 2025
75N92E25P00172
Completed: Period of performance ended Aug 29, 2025THESE REAGENTS ARE NEEDED BY CASANDRA MONTEMAYOR FOR PREPARATION OF METAGENOMIC LIBRARIES FOR SEQUENCING FOR DR. MARK COOKSON. THE…
Department of Health and Human Services · National Institutes of Health
- Obligated
- $0
- Period of performance
- May 30, 2025 – Aug 29, 2025
75N93025P00087
Completed: Period of performance ended Jun 30, 2025DNA AND RNA LIBRARY PREP KITS FOR ILLUMINA
Department of Health and Human Services · National Institutes of Health
- Obligated
- $19.9K
- Period of performance
- Nov 25, 2024 – Jun 30, 2025
75N93025P00902
Completed: Period of performance ended May 30, 2025NEB PCR REAGENTS AND BIOLOGICALS (AMBIS #2259094)
Department of Health and Human Services · National Institutes of Health
- Obligated
- $11.7K
- Period of performance
- Apr 11, 2025 – May 30, 2025
75N92E25P00081
Completed: Period of performance ended May 20, 2025NEBNEXT ULTRA 2 DIRECTIONAL RNA LIBRARY PREP WITH PURIFICATION BEADS
Department of Health and Human Services · National Institutes of Health
- Obligated
- $0
- Period of performance
- Mar 20, 2025 – May 20, 2025
75N92024P00141
Completed: Period of performance ended Apr 19, 2025NEB NEXT ULTRA II DIRECTIONAL RNA LIBRARY PREP.
Department of Health and Human Services · National Institutes of Health
- Obligated
- $38.9K
- Period of performance
- Apr 19, 2024 – Apr 19, 2025
75N95024P00179
Completed: Period of performance ended Feb 28, 2025ENZYMATIC KITS FOR SEQUENCING
Department of Health and Human Services · National Institutes of Health
- Obligated
- $158.9K
- Period of performance
- Mar 18, 2024 – Feb 28, 2025
75N92B25F90004
Completed: Period of performance ended Jan 31, 2025NEW ENGLAND BIOLABS:1105931 [25-000749] 01-NEBNEXT GLOBIN & RRNA DEPLETION KIT (HUMAN/MOUSE/RAT) 96 REACTIONS 02-NEBNEXT MULTIPLEX OLIGOS…
Department of Health and Human Services · National Institutes of Health
- Obligated
- $12.8K
- Period of performance
- Dec 11, 2024 – Jan 31, 2025
75N92B24P00048
Completed: Period of performance ended Jan 20, 2025NEW ENGLAND BIOLABS KITS FOR FOR RNA-SEQ
Department of Health and Human Services · National Institutes of Health
- Obligated
- $17.2K
- Period of performance
- Jan 21, 2024 – Jan 20, 2025
75N92E24P00232
Completed: Period of performance ended Oct 5, 2024NEBNEXT MULTIPLEX OLIGOS FOR ILLUMINA (96 UNIQUE DUAL INDEX PRIMER PAIRS) (384)
Department of Health and Human Services · National Institutes of Health
- Obligated
- $24.3K
- Period of performance
- Aug 5, 2024 – Oct 5, 2024
75N92E24P00115
Completed: Period of performance ended Apr 19, 2024NEBNEXT MULTIPLEX OLIGOS FOR ILLUMINA (96 UNIQUE DUAL INDEX PRIMER PAIRS)
Department of Health and Human Services · National Institutes of Health
- Obligated
- $22.2K
- Period of performance
- Mar 19, 2024 – Apr 19, 2024
75N90018P00688
Completed: Period of performance ended Aug 31, 2019NEW ENGLAND BIOLABS:1105931 [18-015386]
Department of Health and Human Services · National Institutes of Health
- Obligated
- $2.1K
- Period of performance
- Aug 20, 2018 – Aug 31, 2019
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75N98026P01401 NEW ENGLAND BIOLABS:1105931 [26-002792] | Department of Health and Human Services · National Institutes of Health | 334516 · 6505DRUGS AND BIOLOGICALS | $59.5K | Sep 2, 2026 – Sep 1, 2027 | Recompete 6–12 mo: Potential end Sep 1, 2027 (9 months away)AI brief for award 75N98026P01401Bid team for the recompete of award 75N98026P01401 |
33315225P00527670 SCIENTIFIC SUPPLIES | Smithsonian Institution | 325414 · 6640LABORATORY EQUIPMENT AND SUPPLIES | $13.3K | Aug 5, 2025 – Sep 30, 2025 | Completed: Period of performance ended Sep 30, 2025 |
75N92E25P00172 THESE REAGENTS ARE NEEDED BY CASANDRA MONTEMAYOR FOR PREPARATION OF METAGENOMIC LIBRARIES FOR SEQUENCING FOR DR. MARK COOKSON. THE… | Department of Health and Human Services · National Institutes of Health | 325414 · 6505DRUGS AND BIOLOGICALS | $0 | May 30, 2025 – Aug 29, 2025 | Completed: Period of performance ended Aug 29, 2025 |
75N93025P00087 DNA AND RNA LIBRARY PREP KITS FOR ILLUMINA | Department of Health and Human Services · National Institutes of Health | 325414 · 6505DRUGS AND BIOLOGICALS | $19.9K | Nov 25, 2024 – Jun 30, 2025 | Completed: Period of performance ended Jun 30, 2025 |
75N93025P00902 NEB PCR REAGENTS AND BIOLOGICALS (AMBIS #2259094) | Department of Health and Human Services · National Institutes of Health | 325414 · 6640LABORATORY EQUIPMENT AND SUPPLIES | $11.7K | Apr 11, 2025 – May 30, 2025 | Completed: Period of performance ended May 30, 2025 |
75N92E25P00081 NEBNEXT ULTRA 2 DIRECTIONAL RNA LIBRARY PREP WITH PURIFICATION BEADS | Department of Health and Human Services · National Institutes of Health | 325414 · 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | Mar 20, 2025 – May 20, 2025 | Completed: Period of performance ended May 20, 2025 |
75N92024P00141 NEB NEXT ULTRA II DIRECTIONAL RNA LIBRARY PREP. | Department of Health and Human Services · National Institutes of Health | 325413 · 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $38.9K | Apr 19, 2024 – Apr 19, 2025 | Completed: Period of performance ended Apr 19, 2025 |
75N95024P00179 ENZYMATIC KITS FOR SEQUENCING | Department of Health and Human Services · National Institutes of Health | 325414 · 6505DRUGS AND BIOLOGICALS | $158.9K | Mar 18, 2024 – Feb 28, 2025 | Completed: Period of performance ended Feb 28, 2025 |
75N92B25F90004 under 75N98024A00061 NEW ENGLAND BIOLABS:1105931 [25-000749] 01-NEBNEXT GLOBIN & RRNA DEPLETION KIT (HUMAN/MOUSE/RAT) 96 REACTIONS 02-NEBNEXT MULTIPLEX OLIGOS… | Department of Health and Human Services · National Institutes of Health | 325414 · 6505DRUGS AND BIOLOGICALS | $12.8K | Dec 11, 2024 – Jan 31, 2025 | Completed: Period of performance ended Jan 31, 2025 |
75N92B24P00048 NEW ENGLAND BIOLABS KITS FOR FOR RNA-SEQ | Department of Health and Human Services · National Institutes of Health | 325414 · 6810CHEMICALS | $17.2K | Jan 21, 2024 – Jan 20, 2025 | Completed: Period of performance ended Jan 20, 2025 |
75N92E24P00232 NEBNEXT MULTIPLEX OLIGOS FOR ILLUMINA (96 UNIQUE DUAL INDEX PRIMER PAIRS) (384) | Department of Health and Human Services · National Institutes of Health | 325414 · 6505DRUGS AND BIOLOGICALS | $24.3K | Aug 5, 2024 – Oct 5, 2024 | Completed: Period of performance ended Oct 5, 2024 |
75N92E24P00115 NEBNEXT MULTIPLEX OLIGOS FOR ILLUMINA (96 UNIQUE DUAL INDEX PRIMER PAIRS) | Department of Health and Human Services · National Institutes of Health | 325414 · 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $22.2K | Mar 19, 2024 – Apr 19, 2024 | Completed: Period of performance ended Apr 19, 2024 |
75N90018P00688 NEW ENGLAND BIOLABS:1105931 [18-015386] | Department of Health and Human Services · National Institutes of Health | 325414 · 6640LABORATORY EQUIPMENT AND SUPPLIES | $2.1K | Aug 20, 2018 – Aug 31, 2019 | Completed: Period of performance ended Aug 31, 2019 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
Primes it has worked under
- THE JOHNS HOPKINS UNIVERSITY
UEI FTMTDMBR29C7
$51.9K
Subcontractor to this prime · 1 sub-award · latest Dec 18, 2025
- National Institutes of Health
- “MULTIPLEX OLIGOS (ADAPTORS DNA SET 3) FFPE DNA LIBRARY PREP KIT MULTIPLEX OLIGOS (ADAPTORS DNA SET 1) MULTIPLEX OLIGOS (ADAPTORS DNA SET 2) MULTIPLEX OLIGOS (ADAPTORS DNA SET 4)”
Subcontractors it has used
No reported sub-awards as a prime contractor.
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · as of Nov 9, 2026 · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 44 awards
- Total awarded
- $13,459,683
- By phase
- SBIR Phase I: 27
- SBIR Phase II: 12
- STTR Phase I: 3
- STTR Phase II: 2
- By agency
- Department of Health and Human Services: 43
- National Science Foundation: 1
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2013: 4
- 2012: 6
- 2011: 3
- 2010: 1
- 2009: 3
- 2008: 1
- 2007: 2
- 2006: 2
- 2005: 4
- 2004: 4
- 2001: 2
- 2000: 2
- 1999: 3
- 1998: 1
- 1997: 1
- 1996: 2
- 1995: 2
- 1994: 1
Awards (most recent first)
Structure guided rational engineering of novel DNA reagents.
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $99,781
Solicitation PA12-089 (2013) · Topic NIGMS · Research partner: MOUNT SINAI SCHOOL OF MEDICINE
Novel 5-methylcytosine Oxidases
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $251,006
Solicitation PA12-088 (2013) · Topic NIGMS · Research partner: Stub
Structure guided rational engineering of novel DNA reagents.
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2013 · $761,592
Solicitation PA12-089 (2013) · Topic NIGMS · Research partner: MOUNT SINAI SCHOOL OF MEDICINE
Studies of DNA Methyltransferases
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2013 · $1,002,120
Solicitation PA12-088 (2013) · Topic NIGMS · Research partner: Stub
NOVEL 5-HYDROXYMETHYLCYTOSINE SPECIFIC ENZYMES FOR EPIGENETIC STUDIES.
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $278,797
Solicitation PA11-096 (2012) · Topic NIGMS · Research partner: Stub
FINDING NOVEL REAGENTS BY BIOINFORMATICS AND BIOCHEMISTRY
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $218,685
Solicitation PA11-096 (2012) · Topic NIGMS · Research partner: Stub
Studies of DNA Methyltransferases
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $256,651
Solicitation PA12-088 (2012) · Topic NIGMS · Research partner: Stub
In vitro Reconstitution of Protein Translation of Thermus Thermophilus for Direct
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2012 · $960,499
Solicitation PA11-096 (2012) · Topic NIGMS · Research partner: Stub
NOVEL 5-HYDROXYMETHYLCYTOSINE SPECIFIC ENZYMES FOR EPIGENETIC STUDIES.
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2012 · $640,759
Solicitation PA11-096 (2012) · Topic NIGMS · Research partner: Stub
FINDING NOVEL REAGENTS BY BIOINFORMATICS AND BIOCHEMISTRY
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2012 · $874,892
Solicitation PA11-096 (2012) · Topic NIGMS · Research partner: Stub
SBIR Phase I: Synthetic respiration for improved bio-fuels production.
SBIR Phase I · National Science Foundation · 2011 · $148,960
Jan 1, 2011 – Jun 30, 2011
Solicitation year 2010 · Topic BC · Research partner: Stub
Isolation of functional IgGs in the cytoplasm of a novel E. coli expression host
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2011 · $213,422
Solicitation PA10-051 (2011) · Topic NIAID · Research partner: CORNELL UNIVERSITY
NOVEL ENZYME REAGENTS FOR EPIGENETICS STUDIES.
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2011 · $903,660
Solicitation PA09-080 (2011) · Topic NIGMS · Research partner: Stub
NOVEL ENZYME REAGENTS FOR EPIGENETICS STUDIES.
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2010 · $267,417
Solicitation PHS2010-2 (2010) · Topic NIGMS
In vitro Reconstitution of Protein Translation of Thermus Thermophilus for Direct
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2009 · $233,095
Solicitation PHS2009-2 (2009)
DNA Polymerase Database
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2009 · $107,000
Solicitation PHS2009-2 (2009)
DNA Polymerase Database
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2009 · $497,285
Expression System for Isolation of Membrane Associated Protein
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2008 · $107,000
Solicitation PHS2007-2 (2008)
Engineering Useful Type I restriction enzymes
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $107,000
Solicitation year 2007
Simultaneous Control of Expression of Two Genes in Mammalian Tissue Culture
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $132,223
Solicitation year 2007
A Genetic System Able to Screen for Active DNA Demethylation
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2006 · $104,000
Solicitation PHS2006-2 (2006)
Development of a novel nematode/Wolbachia target
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2006 · $750,000
Solicitation PHS2006-2 (2006)
Prevention of Recombinant Protein Aggregation in E.coli
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2005 · $98,880
Solicitation PHS2005-2 (2005)
A universal DNA endonuclease
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2005 · $100,000
Solicitation PHS2005-2 (2005)
Engineering DNA nicking endonucleases
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2005 · $568,340
Solicitation PHS2005-2 (2005)
Showing the 25 most recent of 44 awards.
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325414Biological Product (except Diagnostic) ManufacturingPrimarySmall business under this code’s size standard
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Small business under this code’s size standard
SAM.gov reports this entity as small under 2 of 2 NAICS codes. Size is determined per code (SBA size standards).
Product & service codes (PSC)
- 6640LABORATORY EQUIPMENT AND SUPPLIES
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with NEW ENGLAND BIOLABS, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.